PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1266630
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1266630
Global Snake Antivenom Market Size study & Forecast, by Type ( Polyvalent Heterologous, Monovalent Heterologous) by Application ( Hospitals, Clinics), and Regional Analysis, 2022-2029
Global Snake Antivenom Market is valued at approximately USD 294.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Antivenoms work by boosting the immunological response that occurs in humans after being bitten by a snake. They are made by injecting snake venom into donor animals like sheep or horses. Strong immune systems and the generation of robust antibodies that can attach to snake venom components in these animals enable their own natural defenses to eliminate these toxins.. The Snake Antivenom market is expanding because of factors such as the rising incidence of snakebites and rising government initiatives to raise awareness.
In tropical and subtropical areas, snakebites are the health issue that receives the least attention. The World Health Organization (WHO) estimates that 2.7 million cases of snake envenoming are recorded annually on a global scale. Venomous bites are thought to be the cause of 81,000 to 138,000 fatalities annually. The geographic distribution of these interactions varies greatly. In Asia alone, there are almost 1.7 million snakebite incidents reported per year. Each year, a significant number of snakebites occur in nations in Africa and Latin America as well. One of the main causes of the worldwide increase in snake envenoming incidents is the need for novel products, driving market growth. Additionally, the only medication that may effectively undo the symptoms of snake envenoming is antivenom. Snake's antivenom is a component of basic medical care and is included among the "Essential Medicines" by the WHO. Furthermore, several government and non-government organizations started a number of projects and initiatives to spread the word about snakebite treatment in an effort to lower the fatality rate from snakebites. In order to reduce the number of disabilities and fatalities by snakebites by the year 2030, the WHO launched a strategy for preventing and controlling snakebite envenoming in May 2019. These initiatives have aided these organizations in increasing accessibility and raising awareness in low- and middle-income nations. However, the Lack of adequate price regulation and reimbursement policy stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Snake Antivenom Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key players, and research initiatives by government authorities. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing snake envenoming's, an increase in the number of collaborations for research and development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
- MicroPharm Ltd
- BTG International Inc.
- VINS Bioproducts Limited
- Pfizer Inc.
- SEQIRUS (CSL Limited)
- Inosan Biopharma
- South Africa Vaccine Producers
- Rare Disease Therapeutics, Inc.
- Incepta Vaccine Ltd.
- Bioclon Institute
Recent Developments in the Market:
- In January 2019, BTG International Inc. collaborated with OMNY to increase the usability of its snake antivenom CroFab through distributed ledger technology.
- In November 2020, CSL Sequris (a CSL Limited subsidiary) financed over USD 601.5 million in building a manufacturing facility in the Southern Hemisphere to produce Australian antivenoms, as well as the Q-fever vaccine and pandemic flu vaccine.
Global Snake Antivenom Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Type, Application, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Type:
- Polyvalent Heterologous
- Monovalent Heterologous
By Type:
- Hospitals
- Clinics
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
- 1.2.1. Snake Antivenom Market, by Region, 2019-2029 (USD Million)
- 1.2.2. Snake Antivenom Market, by Type, 2019-2029 (USD Million)
- 1.2.3. Snake Antivenom Market, by Application, 2019-2029 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Snake Antivenom Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Snake Antivenom Market Dynamics
- 3.1. Snake Antivenom Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising Incidence of Snakebites
- 3.1.1.2. Rising government initiatives to raise awareness
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of adequate price regulation and reimbursement policy
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising Penetration by Market Players in Developing Nations
- 3.1.1. Market Drivers
Chapter 4. Global Snake Antivenom Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Snake Antivenom Market, by Type
- 6.1. Market Snapshot
- 6.2. Global Snake Antivenom Market by Type, Performance - Potential Analysis
- 6.3. Global Snake Antivenom Market Estimates & Forecasts by Type 2019-2029 (USD Million)
- 6.4. Snake Antivenom Market, Sub Segment Analysis
- 6.4.1. Polyvalent Heterologous
- 6.4.2. Monovalent Heterologous
Chapter 7. Global Snake Antivenom Market, by Application
- 7.1. Market Snapshot
- 7.2. Global Snake Antivenom Market by Application, Performance - Potential Analysis
- 7.3. Global Snake Antivenom Market Estimates & Forecasts by Application 2019-2029 (USD Million)
- 7.4. Snake Antivenom Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Clinics
Chapter 8. Global Snake Antivenom Market, Regional Analysis
- 8.1. Snake Antivenom Market, Regional Market Snapshot
- 8.2. North America Snake Antivenom Market
- 8.2.1. U.S. Snake Antivenom Market
- 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
- 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Snake Antivenom Market
- 8.2.1. U.S. Snake Antivenom Market
- 8.3. Europe Snake Antivenom Market Snapshot
- 8.3.1. U.K. Snake Antivenom Market
- 8.3.2. Germany Snake Antivenom Market
- 8.3.3. France Snake Antivenom Market
- 8.3.4. Spain Snake Antivenom Market
- 8.3.5. Italy Snake Antivenom Market
- 8.3.6. Rest of Europe Snake Antivenom Market
- 8.4. Asia-Pacific Snake Antivenom Market Snapshot
- 8.4.1. China Snake Antivenom Market
- 8.4.2. India Snake Antivenom Market
- 8.4.3. Japan Snake Antivenom Market
- 8.4.4. Australia Snake Antivenom Market
- 8.4.5. South Korea Snake Antivenom Market
- 8.4.6. Rest of Asia Pacific Snake Antivenom Market
- 8.5. Latin America Snake Antivenom Market Snapshot
- 8.5.1. Brazil Snake Antivenom Market
- 8.5.2. Mexico Snake Antivenom Market
- 8.5.3. Rest of Latin America Snake Antivenom Market
- 8.6. Rest of The World Snake Antivenom Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. MicroPharm
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. BTG International Inc.
- 9.2.3. VINS Bioproducts Limited
- 9.2.4. Pfizer Inc.
- 9.2.5. SEQIRUS (CSL Limited)
- 9.2.6. Inosan Biopharma
- 9.2.7. South Africa Vaccine Producers
- 9.2.8. Rare Disease Therapeutics, Inc.
- 9.2.9. Incepta Vaccine Ltd.
- 9.2.10. Bioclon Institute
- 9.2.1. MicroPharm
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Snake Antivenom Market, report scope
- TABLE 2. Global Snake Antivenom Market estimates & forecasts by Region 2019-2029 (USD Million)
- TABLE 3. Global Snake Antivenom Market estimates & forecasts by Type 2019-2029 (USD Million)
- TABLE 4. Global Snake Antivenom Market estimates & forecasts by Application 2019-2029 (USD Million)
a. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 5. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 6. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 7. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 8. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 9. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 10. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 11. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 12. Global Snake Antivenom Market by segment, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 13. Global Snake Antivenom Market by region, estimates & forecasts, 2019-2029 (USD Million)
- TABLE 14. U.S. Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 15. U.S. Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 16. U.S. Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 17. Canada Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 18. Canada Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 19. Canada Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 20. UK Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 21. UK Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 22. UK Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 23. Germany Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 24. Germany Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 25. Germany Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 26. France Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 27. France Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 28. France Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 29. Italy Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 30. Italy Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 31. Italy Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 32. Spain Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 33. Spain Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 34. Spain Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 35. RoE Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 36. RoE Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 37. RoE Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 38. China Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 39. China Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 40. China Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 41. India Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 42. India Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 43. India Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 44. Japan Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 45. Japan Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 46. Japan Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 47. South Korea Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 48. South Korea Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 49. South Korea Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 50. Australia Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 51. Australia Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 52. Australia Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 53. RoAPAC Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 54. RoAPAC Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 55. RoAPAC Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 56. Brazil Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 57. Brazil Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 58. Brazil Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 59. Mexico Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 60. Mexico Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 61. Mexico Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 62. RoLA Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 63. RoLA Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 64. RoLA Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 65. Row Snake Antivenom Market estimates & forecasts, 2019-2029 (USD Million)
- TABLE 66. Row Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 67. Row Snake Antivenom Market estimates & forecasts by segment 2019-2029 (USD Million)
- TABLE 68. List of secondary sources, used in the study of global Snake Antivenom Market
- TABLE 69. List of primary sources, used in the study of global Snake Antivenom Market
- TABLE 70. Years considered for the study
- TABLE 71. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
List of figures
- FIG 1. Global Snake Antivenom Market, research methodology
- FIG 2. Global Snake Antivenom Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Snake Antivenom Market, key trends 2021
- FIG 5. Global Snake Antivenom Market, growth prospects 2022-2029
- FIG 6. Global Snake Antivenom Market, porters 5 force model
- FIG 7. Global Snake Antivenom Market, pest analysis
- FIG 8. Global Snake Antivenom Market, value chain analysis
- FIG 9. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
- FIG 10. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
- FIG 11. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
- FIG 12. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
- FIG 13. Global Snake Antivenom Market by segment, 2019 & 2029 (USD Million)
- FIG 14. Global Snake Antivenom Market, regional snapshot 2019 & 2029
- FIG 15. North America Snake Antivenom Market 2019 & 2029 (USD Million)
- FIG 16. Europe Snake Antivenom Market 2019 & 2029 (USD Million)
- FIG 17. Asia pacific Snake Antivenom Market 2019 & 2029 (USD Million)
- FIG 18. Latin America Snake Antivenom Market 2019 & 2029 (USD Million)
- FIG 19. Global Snake Antivenom Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
